1. Home
  2. VYGR vs MEI Comparison

VYGR vs MEI Comparison

Compare VYGR & MEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • MEI
  • Stock Information
  • Founded
  • VYGR 2013
  • MEI 1946
  • Country
  • VYGR United States
  • MEI United States
  • Employees
  • VYGR N/A
  • MEI N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • MEI Electrical Products
  • Sector
  • VYGR Health Care
  • MEI Technology
  • Exchange
  • VYGR Nasdaq
  • MEI Nasdaq
  • Market Cap
  • VYGR 232.4M
  • MEI 257.8M
  • IPO Year
  • VYGR 2015
  • MEI N/A
  • Fundamental
  • Price
  • VYGR $3.99
  • MEI $7.48
  • Analyst Decision
  • VYGR Strong Buy
  • MEI Buy
  • Analyst Count
  • VYGR 7
  • MEI 2
  • Target Price
  • VYGR $16.17
  • MEI $11.25
  • AVG Volume (30 Days)
  • VYGR 468.8K
  • MEI 252.5K
  • Earning Date
  • VYGR 11-10-2025
  • MEI 12-03-2025
  • Dividend Yield
  • VYGR N/A
  • MEI 3.77%
  • EPS Growth
  • VYGR N/A
  • MEI N/A
  • EPS
  • VYGR N/A
  • MEI N/A
  • Revenue
  • VYGR $31,316,000.00
  • MEI $1,030,100,000.00
  • Revenue This Year
  • VYGR N/A
  • MEI N/A
  • Revenue Next Year
  • VYGR $107.10
  • MEI $3.41
  • P/E Ratio
  • VYGR N/A
  • MEI N/A
  • Revenue Growth
  • VYGR N/A
  • MEI N/A
  • 52 Week Low
  • VYGR $2.65
  • MEI $5.08
  • 52 Week High
  • VYGR $7.44
  • MEI $17.45
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 41.99
  • MEI 59.14
  • Support Level
  • VYGR $3.81
  • MEI $6.51
  • Resistance Level
  • VYGR $4.30
  • MEI $7.33
  • Average True Range (ATR)
  • VYGR 0.26
  • MEI 0.32
  • MACD
  • VYGR -0.01
  • MEI 0.08
  • Stochastic Oscillator
  • VYGR 38.14
  • MEI 90.72

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.

Share on Social Networks: